The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Becton Dickinson and Co

NYSE: BDX
Last

(U.S.) $139.81

Today's change+4.48 +3.31%
Updated February 12 4:01 PM EST. Delayed by at least 15 minutes.
 

Becton Dickinson and Co

NYSE: BDX
Last

(U.S.) $139.81

Today's change+4.48 +3.31%
Updated February 12 4:01 PM EST. Delayed by at least 15 minutes.

Becton Dickinson and Co up sharply

Becton Dickinson and Co closed up sharply Friday, rallying (U.S.)$4.48 or 3.31% to (U.S.)$139.81. Over the last five days, shares have gained 3.37%, but are down 9.27% for the last year to date. Shares have outperformed the S&P 500 by 8.49% during the last year.

Key company metrics

  • Open(U.S.) $136.87
  • Previous close(U.S.) $135.33
  • High(U.S.) $139.95
  • Low(U.S.) $136.39
  • Bid / Ask-- / --
  • YTD % change-9.27%
  • Volume1,625,444
  • Average volume (10-day)1,637,747
  • Average volume (1-month)1,439,704
  • Average volume (3-month)1,107,388
  • 52-week range(U.S.) $128.87 to (U.S.) $157.50
  • Beta1.01
  • Trailing P/E42.82×
  • P/E 1 year forward16.61×
  • Forward PEG1.23×
  • Indicated annual dividend(U.S.) $2.64
  • Dividend yield1.89%
  • Trailing EPS(U.S.) $3.27
Updated February 12 4:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.14%

Based on its net profit margin of 6.14%, Becton Dickinson and Co is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue2,9863,0603,1202,051
Total other revenue--------
Total revenue2,9863,0603,1202,051
Gross profit1,4081,4161,1881,046
Total cost of revenue1,5781,6441,9321,005
Total operating expense2,6342,7642,9821,758
Selling / general / administrative748743764511
Research & development187195178129
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)121182108113
Other operating expenses, total--------
Operating income352296138293
Interest income (expense), net non-operating-97-99-105-91
Gain (loss) on sale of assets--------
Other--------
Income before tax26619040225
Income after tax22918163216
Income tax, total379-239
Net income22918163216
Total adjustments to net income--------
Net income before extra. items22918163216
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items22918163216
Inc. avail. to common incl. extra. items22918163216
Diluted net income22918163216
Dilution adjustment0------
Diluted weighted average shares216217215200
Diluted EPS excluding extraordinary itemsvalue per share1.060.830.291.08
Dividends per sharevalue per share0.660.600.600.60
Diluted normalized EPSvalue per share1.541.630.621.62